Skip to main content

GOLDMAN SACHS GROUP INC

Position in ATYR — aTYR PHARMA INC

CIK 886982 NEW YORK, NY

Position in ATYR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$220,923
-$49,671 QoQ
Shares Held
283,236
-18.0% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 109 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority Sole 99.60810066516969.ToString("F0")% Shared 0.ToString("F0")% None 0.39189933483031814.ToString("F0")%

Common Shares in ATYR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. ATYR ranks #317 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATYR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $220,923 283,236
2025-12-31 $270,594 345,587
2025-09-30 $496,166 688,165
2025-06-30 $183,913 36,275
2025-03-31 $1,154,596 382,317
2024-12-31 $947,792 261,821
2024-03-31 $423,604 217,233
2023-12-31 $202,433 143,570
2021-12-31 $138,284 18,512